Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis.

Saved in:
Bibliographic Details
Title: Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis.
Authors: Cook LM; Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA., Frieling JS; Tumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nerlakanti N; Tumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA., McGuire JJ; Tumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.; Cancer Biology Ph.D. Program, University of South Florida, Tampa, FL, USA., Stewart PA; Biostatistics and Bioinformatics Shared Resource, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Burger KL; Tumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Cleveland JL; Tumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lynch CC; Tumor Biology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. conor.lynch@moffitt.org.
Source: Oncogene [Oncogene] 2019 Oct; Vol. 38 (44), pp. 6959-6969. Date of Electronic Publication: 2019 Aug 13.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5594
DOI:10.1038/s41388-019-0913-4